Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2301studies shown
Showing 97-108 of 2,301
Drug study icon
Not Yet RecruitingNCT07226232

Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression

This study is comparing Psilocybin with Control for people with Major Depression. Participants receive Psilocybin or Control and complete study visits and assessments.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.From 18 Years to 75 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
Depression
Drug study icon
Not Yet RecruitingNCT07479550

Psilocybin Under Anesthesia Controlled by EEG

This study is comparing Psilocybin (Usona Institute) with placebo for people with Major Depression. Participants receive Psilocybin (Usona Institute) or placebo and complete study visits and assessments.

Remote / online
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 25 Years to 65 Years
Countries
United States
Sponsor
Stanford University
Condition
Depression
Other study type icon
Not Yet RecruitingNCT06101914

Studying Patterns in Patient Engagement Among Treatment Resistant Depression Patients

This study is looking at meticulously scrutinize trial completion rates and voluntary withdrawals within this specific patient group for people with Treatment Resistant Depression. Participants are followed over time so researchers can learn from clinical and follow-up information.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionOtherOver 18 Years
Countries
United States
Sponsor
Power Life Sciences Inc.
Condition
Depression
Drug study icon
Enrolling By InvitationNCT06605105

Phase III Long-term Extension study to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)

This study is looking at care and outcomes for people with depression. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 85 Years
Countries
United States, Australia
Sponsor
Cybin IRL Limited
Condition
Depression
Drug study icon
RecruitingNCT07300969

Effectiveness of DT-101 in depression

This study is recruiting in the United States, in the United Kingdom, in Bulgaria, .... It is testing DT-101 for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 75 Years
Countries
United States, United Kingdom, Bulgaria, ...
Sponsor
Draig Therapeutics Ltd
Condition
Depression
Behavioral study icon
RecruitingNCT07025720

Accelerated Intermittent Theta Burst Stimulation for Adolescent and Young Adult Depression With Elevated Suicide prevention

This study is looking at whether TMS can help people with depression or Suicide prevention. Participants receive a study treatment and complete follow-up visits and assessments.

In United States
Why is this study shown?

This study is directly about Depression.

Depression, SuicidalityBehavioralFrom 15 Years to 25 Years
Countries
United States
Sponsor
University of California, Davis
Condition
Depression, Suicidality
Device study icon
RecruitingNCT07217444

Improving Outcomes in Adolescent Inpatient Depression With Deep Transcranial Magnetic Stimulation

This observational study is following people with depression, Suicide prevention, or Hospitalization in Children to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In United States
Why is this study shown?

This study is directly about Depression.

Depression, SuicidalityDeviceA study involving a tool, app, wearable, test, or medical device.From 14 Years to 18 Years
Countries
United States
Sponsor
Children's Hospital Medical Center, Cincinnati
Condition
Depression, Suicidality
Behavioral study icon
RecruitingNCT07159061

Neurofeedback to Treat Depression - 2

This study is comparing Active Closed Loop Real Time fMRI Neurofeedback with Sham Comparator: Sham Neurofeedback for people with depression. Participants receive Active Closed Loop Real Time fMRI Neurofeedback or Sham Comparator: Sham Neurofeedback and complete study visits and assessments.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Pennsylvania
Condition
Depression
Device study icon
RecruitingNCT07294924

Prediction of REsponse to Depression Interventions (Accelerated rTMS) Using Clinical and TD-fNIRS Measurements

This observational study is following people with depression or Fnirs to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionOtherFrom 18 Years to 75 Years
Countries
United States
Sponsor
Kernel
Condition
Depression
Drug study icon
RecruitingNCT05922878

ALTO-300 in MDD

This study is looking at determine efficacy differences between ALTO-300 and placebo, used adjunctively to an antidepressant, related to patient characteristics for people with depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Alto Neuroscience
Condition
Depression
Behavioral study icon
RecruitingNCT07076342

The Role of mGluR5 in CBT-I

This observational study is following people with depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

Remote / online
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralOver 18 Years
Countries
United States
Sponsor
Stony Brook University
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.